FRESENIUS MEDICAL CARE AG (FME.DE) Stock Earnings & Estimates
FRA:FME - DE0005785802 - Common Stock
41.99 EUR
+0.28 (+0.67%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.398B 10.10% | 19.454B 0.29% | 19.336B -0.61% | 19.742B 2.10% | 20.36B 3.13% | 21.254B 4.39% | 22.398B 5.38% | 23.402B 4.48% | 24.895B 6.38% | 25.157B 1.05% | 26.054B 3.57% | |
| EBITDA YoY % growth | 3.125B -8.15% | 3.03B -3.03% | 3.008B -0.73% | 3.657B 21.57% | 3.92B 7.19% | 4.106B 4.74% | 4.139B 0.80% | 4.358B 5.29% | 4.781B 9.71% | 5.024B 5.08% | 5.22B 3.90% | |
| EBIT YoY % growth | 1.287B -27.66% | 1.278B -0.65% | 1.266B -0.97% | 2.085B 64.70% | 2.286B 9.64% | 2.496B 9.19% | 2.757B 10.46% | 2.979B 8.05% | 2.994B 0.50% | 3.137B 4.78% | 3.25B 3.60% | |
| Operating Margin | 6.63% | 6.57% | 6.55% | 10.56% | 11.23% | 11.74% | 12.31% | 12.73% | 12.03% | 12.47% | 12.47% | |
| EPS YoY % growth | 3.10 -10.14% | 2.57 -17.23% | 3.25 26.66% | 3.83 17.89% | 4.20 9.64% | 4.92 17.24% | 5.49 11.53% | 6.08 10.69% | 7.39 21.57% | 6.99 -5.39% | 7.53 7.64% |
All data in EUR
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.90 10.36% | 0.95 4.29% |
| Revenue Q2Q % growth | 4.957B 4.14% | 4.831B -5.00% |
| EBITDA Q2Q % growth | 945.37M -44.11% | 1.094B -44.21% |
| EBIT Q2Q % growth | 550.47M 29.17% | 622.7M 184.77% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.91 30.00% | 0.79 | 0.12 | 14.89% |
| Q1 2025 Q2Q % growth | 0.84 2.44% | 0.66 | 0.18 | 27.17% |
| Q4 2024 Q2Q % growth | 0.91 3.41% | 0.79 | 0.12 | 15.03% |
| Q3 2024 Q2Q % growth | 0.82 43.86% | 0.65 | 0.17 | 25.81% |
| Q2 2024 Q2Q % growth | 0.70 17.45% | 0.68 | 0.02 | 2.71% |
| Q1 2024 Q2Q % growth | 0.82 57.69% | 0.60 | 0.22 | 37.27% |
| Q4 2023 Q2Q % growth | 0.88 2.33% | 0.94 | -0.06 | -6.11% |
| Q3 2023 Q2Q % growth | 0.57 -27.85% | 0.52 | 0.05 | 9.44% |
| Q2 2023 Q2Q % growth | 0.60 -22.60% | 0.51 | 0.09 | 16.93% |
| Q1 2023 Q2Q % growth | 0.52 -23.53% | 0.52 | 0.00 | -0.29% |
| Q4 2022 Q2Q % growth | 0.86 -4.44% | 0.79 | 0.07 | 8.43% |
| Q3 2022 Q2Q % growth | 0.79 -15.96% | 0.68 | 0.11 | 15.76% |
| Q2 2022 Q2Q % growth | 0.77 1.32% | 0.83 | -0.06 | -7.29% |
| Q1 2022 Q2Q % growth | 0.68 -20.00% | 0.70 | -0.02 | -2.50% |
| Q4 2021 Q2Q % growth | 0.90 -29.13% | 0.88 | 0.02 | 2.03% |
| Q3 2021 Q2Q % growth | 0.94 -22.31% | 0.92 | 0.02 | 2.46% |
| Q2 2021 Q2Q % growth | 0.76 -36.67% | 0.76 | 0.00 | 0.20% |
| Q1 2021 Q2Q % growth | 0.85 -10.53% | 0.80 | 0.05 | 5.83% |
| Q4 2020 Q2Q % growth | 1.27 -6.62% | 1.21 | 0.06 | 4.92% |
| Q3 2020 Q2Q % growth | 1.21 | 1.16 | 0.05 | 4.36% |
| Q2 2020 Q2Q % growth | 1.20 30.43% | 1.09 | 0.11 | 10.07% |
| Q1 2020 Q2Q % growth | 0.95 -8.65% | 0.87 | 0.08 | 8.84% |
| Q4 2019 Q2Q % growth | 1.36 | 1.32 | 0.04 | 2.79% |
| Q3 2019 Q2Q % growth | 1.21 | 1.09 | 0.12 | 11.31% |
| Q2 2019 Q2Q % growth | 0.92 | 0.97 | -0.05 | -4.96% |
| Q1 2019 Q2Q % growth | 1.04 | 0.93 | 0.11 | 11.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.792B 0.55% | 4.957B | -165M | -3.33% |
| Q1 2025 Q2Q % growth | 4.881B 3.31% | 4.751B | 130M | 2.74% |
| Q4 2024 Q2Q % growth | 5.085B 1.94% | 4.795B | 290M | 6.05% |
| Q3 2024 Q2Q % growth | 4.76B -3.57% | 4.979B | -219M | -4.40% |
| Q2 2024 Q2Q % growth | 4.766B -1.22% | 5.014B | -248M | -4.95% |
| Q1 2024 Q2Q % growth | 4.725B 0.43% | 4.681B | 43.522M | 0.93% |
| Q4 2023 Q2Q % growth | 4.988B -0.18% | 5.002B | -14M | -0.28% |
| Q3 2023 Q2Q % growth | 4.936B -3.14% | 4.952B | -16M | -0.32% |
| Q2 2023 Q2Q % growth | 4.825B 1.44% | 4.824B | 1M | 0.02% |
| Q1 2023 Q2Q % growth | 4.704B 3.43% | 4.767B | -62.782M | -1.32% |
| Q4 2022 Q2Q % growth | 4.997B 7.53% | 5.054B | -57.198M | -1.13% |
| Q3 2022 Q2Q % growth | 5.096B 14.74% | 5.093B | 3.166M | 0.06% |
| Q2 2022 Q2Q % growth | 4.757B 10.10% | 4.811B | -54.32M | -1.13% |
| Q1 2022 Q2Q % growth | 4.548B 8.03% | 4.516B | 32.369M | 0.72% |
| Q4 2021 Q2Q % growth | 4.647B 5.61% | 4.654B | -6.976M | -0.15% |
| Q3 2021 Q2Q % growth | 4.441B 0.63% | 4.517B | -75.634M | -1.67% |
| Q2 2021 Q2Q % growth | 4.32B -5.20% | 4.363B | -42.83M | -0.98% |
| Q1 2021 Q2Q % growth | 4.21B -6.19% | 4.272B | -61.875M | -1.45% |
| Q4 2020 Q2Q % growth | 4.4B -3.93% | 4.495B | -94.846M | -2.11% |
| Q3 2020 Q2Q % growth | 4.414B -0.12% | 4.439B | -25.232M | -0.57% |
| Q2 2020 Q2Q % growth | 4.557B 4.89% | 4.504B | 53.345M | 1.18% |
| Q1 2020 Q2Q % growth | 4.488B 8.60% | 4.466B | 21.796M | 0.49% |
| Q4 2019 Q2Q % growth | 4.58B | 4.628B | -48.037M | -1.04% |
| Q3 2019 Q2Q % growth | 4.419B | 4.461B | -41.997M | -0.94% |
| Q2 2019 Q2Q % growth | 4.345B | 4.395B | -49.968M | -1.14% |
| Q1 2019 Q2Q % growth | 4.133B | 4.151B | -18.443M | -0.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.14% | 69.06% | 3.39% | 3.39% |
| Revenue | -0.84% | -5.76% | -0.27% | -0.62% |